Refractive
Spring 2024
by Karolinne Rocha, MD, PhD
Refractive Editor
ICLs are back in the spotlight to kick off the first edition of EyeWorld in 2024. One may recall that we ended 2023 with them as well in “Expanding experience with the EVO ICL.” In this article, our colleagues discussed patient selection, increased interest, and benefits of the lens.
In this issue, Mark Packer, MD, Neda Nikpoor, MD, and Roger Zaldivar, MD, take a closer look at ICL sizing and vault concerns, which may be more forgiving than the state of one’s New Year’s resolutions at this time of the year.
“Taking a closer look at ICL sizing and vault concerns” relates the findings of Dr. Packer’s meta-analysis of more than 20 published studies. Results were similar, around 450–500 microns (200-micron standard deviation), regardless of the methodology. Dr. Nikpoor’s methodology, for example, includes preop testing of refractive screening tests, IOLMaster, Pentacam, digital caliper for primary white-to-white measurement, and UBM (Dougherty nomogram), in addition to contact lens over refraction.
“I personally look forward to the clinical data to come, specifically as it relates to the providing our patients with vision free of dysphotopsias.”
Also in this issue, Scott Barnes, MD, Erik Mertens, MD, Audrey Talley Rostov, MD, William Trattler, MD, and Blake Williamson, MD, relate their procedures for defining and measuring anterior chamber depth in “Clearing up the confusion: get the right anterior chamber depth for ICL.” The takeaway for both of these articles is the need for precision—be it in a device or nomogram to address vault or in a methodology or calculation to acquire anterior chamber depth—to maximize patient outcomes.
Advances in new platforms and designs are always exciting, and the current accommodating lenses in development, which are detailed in “Current accommodating lenses in development,” are no exception. It’s no easy feat to attempt to replace crystalline lens functions, but I personally look forward to the clinical data to come, specifically as it relates to the providing our patients with vision free of dysphotopsias.
Refractive surgery and more are on the agenda for the 2024 ASCRS Annual Meeting, taking place April 5–8 in Boston and celebrating 50 years of the organization. In fact, one can find Dr. Talley Rostov among the moderators for ASCRS Refractive Day 2024. I look forward to her insights on the subspecialty day and those of all of our colleagues throughout the Annual Meeting as we come together to learn and gather insight from one another.
